drugset / Trial / NCT00892450

Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease

NCT00892450

Completed 12 enrolled US Department of Veterans Affairs
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this research study is to investigate the cognitive (thinking, memory, knowledge, intelligence) side effects of two medications commonly used to treat overactive bladder (OAB) symptoms in veteran patients with Parkinson's disease (PD) seen at the Philadelphia PADRECC.

Timeline

Start
2009-05
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Darifenacin Small molecule
Subject Oxybutynin Small molecule